| News Article Or Scientific Reference | Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | PPAR gamma agonists can be expected to potentiate the efficacy of metronomic chemotherapy through CD36 up-regulation. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | Milk consumption is a risk factor for prostate cancer in Western countries: evidence from cohort studies. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) stud | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. | Mikael Nordfors | 0 | 12 years 7 months ago |
| News Article Or Scientific Reference | The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline | Mikael Nordfors | 0 | 12 years 8 months ago |
| News Article Or Scientific Reference | Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. | Mikael Nordfors | 0 | 12 years 8 months ago |
| News Article Or Scientific Reference | Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention | Mikael Nordfors | 0 | 12 years 8 months ago |
| News Article Or Scientific Reference | Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecula | Mikael Nordfors | 0 | 12 years 8 months ago |
| News Article Or Scientific Reference | Boswellic acids: biological actions and molecular targets. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Role of everolimus in the treatment of renal cell carcinoma. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | A phase II clinical trial of sorafenib in androgen-independent prostate cancer. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | The anti-angiogenic basis of metronomic chemotherapy. | Mikael Nordfors | 0 | 12 years 9 months ago |
| News Article Or Scientific Reference | Psychodynamic psychotherapy, therapeutic touch and cancer. A review of the method of intervention and studv of 75 cases | Mikael Nordfors | 0 | 12 years 9 months ago |
